242 related articles for article (PubMed ID: 36306669)
1. Prevalence and quality-of-life burden of vasomotor symptoms associated with menopause: A European cross-sectional survey.
Nappi RE; Siddiqui E; Todorova L; Rea C; Gemmen E; Schultz NM
Maturitas; 2023 Jan; 167():66-74. PubMed ID: 36306669
[TBL] [Abstract][Full Text] [Related]
2. Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden.
Nappi RE; Kroll R; Siddiqui E; Stoykova B; Rea C; Gemmen E; Schultz NM
Menopause; 2021 May; 28(8):875-882. PubMed ID: 34033602
[TBL] [Abstract][Full Text] [Related]
3. Vasomotor and sexual symptoms in older Australian women: a cross-sectional study.
Zeleke BM; Bell RJ; Billah B; Davis SR
Fertil Steril; 2016 Jan; 105(1):149-55.e1. PubMed ID: 26450529
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and impact of vasomotor symptoms due to menopause among women in Brazil, Canada, Mexico, and Nordic Europe: a cross-sectional survey.
Todorova L; Bonassi R; Guerrero Carreño FJ; Hirschberg AL; Yuksel N; Rea C; Scrine L; Kim JS
Menopause; 2023 Dec; 30(12):1179-1189. PubMed ID: 37847872
[TBL] [Abstract][Full Text] [Related]
5. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women.
Blümel JE; Chedraui P; Baron G; Belzares E; Bencosme A; Calle A; Danckers L; Espinoza MT; Flores D; Gomez G; Hernandez-Bueno JA; Izaguirre H; Leon-Leon P; Lima S; Mezones-Holguin E; Monterrosa A; Mostajo D; Navarro D; Ojeda E; Onatra W; Royer M; Soto E; Tserotas K; Vallejo S;
Menopause; 2011 Jul; 18(7):778-85. PubMed ID: 21407137
[TBL] [Abstract][Full Text] [Related]
6. Bothersome menopausal symptoms amongst postmenopausal Iranian women.
Fooladi E; Bell RJ; Masoumi M; Azizi M; Atarod Z; Davis SR
Climacteric; 2018 Dec; 21(6):586-593. PubMed ID: 30145921
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and severity of vasomotor symptoms and joint pain in women at midlife in Bangladesh: a population-based survey.
Islam RM; Bell RJ; Billah B; Hossain MB; Davis SR
Menopause; 2016 Jul; 23(7):731-9. PubMed ID: 26926325
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, severity, and associated factors in women in East Asia with moderate-to-severe vasomotor symptoms associated with menopause.
Yu Q; Chae HD; Hsiao SM; Xie J; Blogg M; Sumarsono B; Kim S
Menopause; 2022 May; 29(5):553-563. PubMed ID: 35231007
[TBL] [Abstract][Full Text] [Related]
9. Vasomotor symptoms and neurovegetative comorbidities on the menopause: insights from an Italian quantitative research.
Graziottin A; Banerji V; Hall G
Gynecol Endocrinol; 2019 Sep; 35(9):762-766. PubMed ID: 31266379
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the impact, treatment patterns, and patient and physician perceptions of vasomotor symptoms associated with menopause in Europe and the United States.
Stute P; Cano A; Thurston RC; Small M; Lee L; Scott M; Siddiqui E; Schultz NM
Maturitas; 2022 Oct; 164():38-45. PubMed ID: 35785563
[TBL] [Abstract][Full Text] [Related]
11. Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years.
Gartoulla P; Worsley R; Bell RJ; Davis SR
Menopause; 2018 Nov; 25(11):1331-1338. PubMed ID: 30358730
[TBL] [Abstract][Full Text] [Related]
12. Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years.
Gartoulla P; Worsley R; Bell RJ; Davis SR
Menopause; 2015 Jul; 22(7):694-701. PubMed ID: 25706184
[TBL] [Abstract][Full Text] [Related]
13. Assessment of women's treatment preferences for vasomotor symptoms due to menopause.
Shiozawa A; Thurston RC; Cook E; Yang H; King DD; Kristy RM; Mancuso S
Expert Rev Pharmacoecon Outcomes Res; 2023; 23(10):1117-1128. PubMed ID: 37650213
[TBL] [Abstract][Full Text] [Related]
14. Vasomotor symptom characteristics: are they risk factors for incident diabetes?
Gray KE; Katon JG; LeBlanc ES; Woods NF; Bastian LA; Reiber GE; Weitlauf JC; Nelson KM; LaCroix AZ
Menopause; 2018 May; 25(5):520-530. PubMed ID: 29206771
[TBL] [Abstract][Full Text] [Related]
15. Vasomotor symptoms in women over 60: results from the Data Registry on Experiences of Aging, Menopause, and Sexuality (DREAMS).
David PS; Kling JM; Vegunta S; Faubion SS; Kapoor E; Mara KC; Schroeder DR; Hilsaca KF; Kuhle CL
Menopause; 2018 Oct; 25(10):1105-1109. PubMed ID: 29738420
[TBL] [Abstract][Full Text] [Related]
16. Menopause-specific quality of life during ovarian aging among Chinese women: A prospective cohort study.
Tang R; Luo M; Fan Y; Peng Y; Wang Y; Liu G; Wang Y; Lin S; Chen R
Maturitas; 2022 Mar; 157():7-15. PubMed ID: 35120675
[TBL] [Abstract][Full Text] [Related]
17. Vasomotor symptoms in aging Chinese women: findings from a prospective cohort study.
Li J; Luo M; Tang R; Sun X; Wang Y; Liu B; Cui J; Liu G; Lin S; Chen R
Climacteric; 2020 Feb; 23(1):46-52. PubMed ID: 31269826
[No Abstract] [Full Text] [Related]
18. Relationships Between Vasomotor Symptoms and Mood in Midlife Urban Chinese Women: Observations in a Prospective Study.
Tang R; Luo M; Li J; Peng Y; Wang Y; Liu B; Liu G; Wang Y; Lin S; Chen R
J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32841324
[TBL] [Abstract][Full Text] [Related]
19. Psychometric Evaluation of the MENQOL Instrument in Women Experiencing Vasomotor Symptoms Associated with Menopause.
Schultz NM; Morga A; Siddiqui E; Rhoten SE
Adv Ther; 2024 Jun; 41(6):2233-2252. PubMed ID: 38396203
[TBL] [Abstract][Full Text] [Related]
20. Duration of menopausal vasomotor symptoms over the menopause transition.
Avis NE; Crawford SL; Greendale G; Bromberger JT; Everson-Rose SA; Gold EB; Hess R; Joffe H; Kravitz HM; Tepper PG; Thurston RC;
JAMA Intern Med; 2015 Apr; 175(4):531-9. PubMed ID: 25686030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
